文献速递甲状腺疾病

放射性碘治疗后萎缩性甲状腺患者左甲状腺素单药治疗的血清甲状腺激素平衡

Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
PubMed 文献 · Thyroid · 2019-09-13

回顾性研究446例因放射性碘治疗Graves病致甲减并接受左甲状腺素(LT4)治疗的患者,其中80%(356/446)甲状腺体积低于对照95%参考范围下限。在313例萎缩性甲状腺患者中,TSH正常者血清fT3显著低于对照,而轻度抑制TSH者的fT3与对照相当,提示此类患者可能需要轻度抑制TSH以维持正常fT3水平。

要点

  • 放射性碘治疗后多数LT4治疗患者甲状腺体积缩小,fT3水平偏低。
  • TSH正常者fT3显著低于对照,轻度抑制TSH者fT3与对照相当。
  • 甲状腺体积小于5 mL者fT3显著降低,体积大于10 mL者与对照相当。

核心结论

  • 放射性碘治疗Graves病后多数LT4治疗患者的血清甲状腺激素平衡与无甲状腺患者相似。
  • 对此类患者,LT4治疗需轻度抑制TSH才能达到正常fT3水平。

研究设计与样本

  • 回顾性研究,纳入446例因放射性碘治疗Graves病致甲减并接受LT4治疗且行超声检查的患者。
  • 与甲状腺完整的甲状腺功能正常匹配对照组比较血清fT4和fT3水平。
  • 按甲状腺体积对TSH正常患者分层评估血清甲状腺激素水平。

主要发现

  • 446例中356例(80%)甲状腺体积低于对照95%参考范围下限。
  • 排除43例TSH高者后评估313例萎缩性甲状腺患者:8例TSH强烈抑制者fT3显著高于对照(p < 0.001)。
  • 27例TSH轻度抑制者fT3与对照相当(p = 0.386),278例TSH正常者fT3显著低于对照(p < 0.001)。
  • 326例TSH正常者中,267例甲状腺体积小于5 mL和46例5–10 mL者fT3均显著低于对照(p < 0.001)。
  • 13例甲状腺体积大于10 mL者fT3与对照相当(p = 0.844)。

关键数值与推荐

  • 甲状腺体积低于对照95%参考范围下限者占80%(356/446)。
  • TSH正常者fT3显著低于对照(p < 0.001);TSH轻度抑制者fT3与对照相当(p = 0.386)。
  • 甲状腺体积小于5 mL及5–10 mL者fT3显著低于对照(p < 0.001);大于10 mL者与对照相当(p = 0.844)。

临床怎么用

  • 对放射性碘治疗后萎缩性甲状腺的LT4治疗患者,评估fT3水平有助于判断甲状腺激素平衡。
  • TSH正常但fT3偏低者,可考虑轻度抑制TSH以达标,但需权衡风险。

局限性

  • 为回顾性研究,可能存在选择偏倚。
  • 未报告LT4剂量、随访时间及临床结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Some studies reported that among athyreotic patients on levothyroxine (LT4) after total thyroidectomy, patients with normal serum thyrotropin (TSH) levels had mildly low serum free triiodothyronine (fT3) levels, whereas patients with mildly suppressed serum TSH levels had normal serum fT3 levels. The reduction of the thyroid volume (TV) after radioiodine treatment for Graves' disease is well known; however, a few studies evaluated thyroidal function including serum triiodothyronine (T3) levels of hypothyroid patients on LT4 after radioiodine treatment in detail. Methods: We retrospectively studied 446 patients treated with LT4 for radioiodine-induced hypothyroidism and who had undergone ultrasonography. We compared serum fT4 and fT3 levels in hypothyroid patients on LT4 who presented an atrophic thyroid change after radioiodine treatment, with those in the euthyroid matched control group with intact thyroids. We also stratified patients with normal TSH levels according to TV and evaluated serum thyroid hormone levels. Results: In 356 of 446 (80%) patients, TV was lower than the lower limit of the 95% reference range of controls. Excluding 43 patients with high serum TSH levels, we assessed thyroid function test results in 313 patients with atrophic thyroid glands. Of these cases, eight patients with strongly suppressed TSH levels had serum fT3 levels that were significantly higher than those in controls (p < 0.001). Overall, 27 patients with mildly suppressed TSH levels had serum fT3 levels equivalent to those in controls (p = 0.386), whereas 278 patients with normal TSH levels had serum fT3 levels that were significantly lower than those in controls (p < 0.001). We also assessed fT3 levels relative to TV in 326 patients with normal TSH levels. Of these cases, in 267 patients with TV less than 5 mL and in 46 patients with TV between 5 and 10 mL, serum fT3 levels were significantly lower than those in controls (p < 0.001). In 13 patients with TV more than 10 mL, serum fT3 levels were equivalent to those in controls (p = 0.844). Conclusions: Serum thyroid hormone balance in most patients on LT4 after radioiodine treatment for Graves' disease was similar to that in athyreotic patients on LT4. Mild TSH suppression with LT4 is needed to achieve normal fT3 levels in such patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ito M, Kawasaki M, Danno H, et al. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease. Thyroid. 2019. PMID: 31411123. doi:10.1089/thy.2019.0135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。